Lunai Bioworks Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.1907
-0.0080 (-4.03%)
At close: Sep 15, 2025, 4:00 PM EDT
0.1934
+0.0027 (1.42%)
After-hours: Sep 15, 2025, 7:54 PM EDT
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $44.04 million as of September 15, 2025. Its market cap has decreased by -56.66% in one year.
Market Cap
44.04M
Enterprise Value
49.98M
1-Year Change
-56.66%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since December 11, 2018, Lunai Bioworks's market cap has decreased from $252.00M to $44.04M, a decrease of -82.52%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 34.30M | -74.15% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
| Dec 11, 2018 | 252.00M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |